| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net increase (decrease) in cash | 1,914,670 | 2,517,987 |
| Cash and cash equivalents at beginning of period | 406,408 | - |
| Cash and cash equivalents at end of period | 2,321,078 | - |
Hepion Pharmaceuticals, Inc. (CTRVP)
Hepion Pharmaceuticals, Inc. (CTRVP)